Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420575 · ClinicalTrials.gov registry record · NA
Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia
A NA study, sponsored by VA Nebraska Western Iowa Health Care System.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01420575 is a NA study that was terminated before completion, run by VA Nebraska Western Iowa Health Care System. The registered enrollment target is 8 participants.
The verdict
NCT01420575, a NA study, was terminated before completion, sponsored by VA Nebraska Western Iowa Health Care System.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
We hypothesize that the use of a visual decision aid tool to educate patients regarding potential harm with respect to weight gain with olanzapine versus perphenazine can lead to better shared decision making by patients, increase rates of antipsychotic switches and promote weight loss in overweight patients with schizophrenia/schizoaffective disorder. Our specific aims are the following: 1. To investigate the effects of a visual decision aid, versus care as usual, on patients' perceived difficulties in medical decision making regarding switching antipsychotics in overweight veterans with schizophrenia or schizoaffective disorder. 2. To investigate the effects of a visual decision aid and a shared decision making model on rate of medication switches (from olanzapine to perphenazine) in overweight veterans with schizophrenia or schizoaffective disorder. 3. To investigate the effects of a visual decision making aid and shared decision making model on BMI in overweight veterans who switch from olanzapine to perphenazine therapy.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Visual Decision Aid and Shared Decision Making Model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01420575
The ClinicalTrials.gov registry entry for NCT01420575 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Nebraska Western Iowa Health Care System, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT01420575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01420575 about?
NCT01420575 is a clinical study titled "Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia". We hypothesize that the use of a visual decision aid tool to educate patients regarding potential harm with respect to weight gain with olanzapine versus perphenazine can lead to better shared decision making by patients, increase rates of antipsychotic switches and promote weight loss in overweight...
What is the current status of trial NCT01420575?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2010-10. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01420575?
The interventions under investigation include: Usual Care (BEHAVIORAL), Visual Decision Aid and Shared Decision Making Model (BEHAVIORAL).
Who is sponsoring clinical trial NCT01420575?
This trial is sponsored by VA Nebraska Western Iowa Health Care System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.